Przegląd Gastroenterologiczny

Use of three different supraglottic airway devices as a conduit for tracheal intubation in surgery: a randomised comparative study

  1. Department of Anesthesiology and Intensive Care, University General Hospital of Patras, Rio, Greece

  2. Second Department of Surgery, Medical School, Democritus University of Thrace, Alexandroupolis, Greece

  3. Department of General Surgery, University General Hospital of Patras, Rio, Greece

  4. Department of Otolaryngology, University General Hospital of Patras, Rio, Greece

  5. First Department of Otolaryngology, Hippokration General Hospital, National and Kapodistrian University of Athens, Greece

  6. Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, Kaiserslautern, Germany

Gastroenterology Rev

Online publish date: 2026/09/21
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Supraglottic airway devices (SADs) can serve as conduits for tracheal intubation (TI) during difficult airway management.

Aim

This study aims to assess three different SADs used for TI in patients undergoing elective surgery under general anaesthesia, comparing one first-generation SAD with two second-generation SADs.

Material and methods

This prospective, randomised clinical study included 193 adult patients (ASA I-II) who were randomly assigned to three groups. The first group underwent blind TI using the intubating LMA (Fastrach™), the second group via the I-gel®, and the third group through the LMA Protector™, with the latter two procedures guided by a flexible bronchoscope. The primary outcome measured was the time to successful tracheal intubation following placement of the SAD. Secondary outcomes included time from SAD introduction to ventilation, first pass success rates for both SAD and intubation, total procedure time and the oropharyngeal leak pressure.

Results

I-gel® had a longer time to TI than Fastrach™ (p < 0.001) and Protector™ (p = 0.03), and Protector™ was slower than Fastrach™ (p < 0.001). The time from SAD introduction to ventilation was longer with Fastrach™ and Protector™ compared to I-gel® (p < 0.001). Total procedure time was extended in the Protector™ group compared to both Fastrach™ and I-gel® (p < 0.001 for both), and in I-gel® compared to Fastrach™ (p < 0.001). TI success rates were comparable for I-gel® (95.4%) and Protector™ (96.9%), but lower for Fastrach™ (92.2%). Notably, oropharyngeal leak pressure was significantly higher with the Protector™ compared to the I-gel® (p < 0.001).

Conclusions

I-gel® and ProtectorTM produced similar outcomes as conduits for assisted intubation, both achieving high TI success rates. Fastrach™, however, was associated with a statistically significant reduction in unassisted intubation time. These results suggest that additional research in this area may be warranted.

Share
without publication fees